ABVC Biopharma 2024 Form 8-K Amendment: Key Insights Revealed

Here are the key insights extracted from the provided section of the financial report:

1. Entity Information:

• Company Name: ABVC Biopharma, Inc.
• CIK: 0001173313
• IRS Employer Identification Number: 26-0014658
• Address: 44370 Old Warm Springs Blvd., Fremont, CA 94538
• Phone Number: (510) 668-0881

2. Filing Information:

• Form Type: Amendment No. 1 to Form 8-K
• Filing Date: July 12, 2024
• SEC File Number: 001-40700

3. Stock Information:

• Common Stock: Par value of $0.001 per share
• Ticker Symbol: ABVC
• Exchange: NASDAQ

4. Filing Context:

• Filing Date Context: The context period for this filing is specifically July 12, 2024.

5. Measurement Units:

• Currency: All financial figures are reported in United States Dollars (USD).
• Shares: The units for stock measurement are shares.

6. General Notes:

• This is an amendment to a previous filing, which suggests that there may have been updates or corrections made to the original Form 8-K.
• The filing is categorized under XBRL (Extensible Business Reporting Language), which is a standard for the electronic communication of business and financial data.

This analysis provides a concise overview of the essential details contained within the financial report section provided.